Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
The Capsule
The Capsule
Page 2 of 9
Newsletters
Google Health is being dismantled, but Big Tech’s quixotic health ambitions persist
By
Sy Mukherjee
August 26, 2021
Newsletters
Another COVID booster unknown: Will more doses for the vaccinated cause new variants?
By
Sy Mukherjee
August 19, 2021
Newsletters
There are no authorized COVID booster shots. More than one million Americans have gotten them anyway
By
Sy Mukherjee
August 12, 2021
Newsletters
Moderna’s unlikely journey to rivaling Big Pharma giants’ valuations
By
Sy Mukherjee
August 5, 2021
Newsletters
Offices, employees, and customers: The COVID mask conundrum
By
Sy Mukherjee
July 29, 2021
Newsletters
Africa’s first mRNA vaccine production deal has finally appeared
By
David Meyer
July 22, 2021
Newsletters
COVID vaccines, variants, and boosters are a nuanced storm
By
Sy Mukherjee
July 15, 2021
Newsletters
The never ending Biogen Alzheimer’s drug saga delivers yet another twist
By
Sy Mukherjee
July 8, 2021
Newsletters
The CRISPR breakthrough that can change the future of gene editing
By
Sy Mukherjee
July 2, 2021
Newsletters
The delta between the Delta variants
By
Sy Mukherjee
June 24, 2021
Newsletters
Three Black health care diversity officers. One united goal
By
Sy Mukherjee
June 17, 2021
Newsletters
What comes next after the Biogen Alzheimer’s drug approval
By
Sy Mukherjee
June 10, 2021
Newsletters
The health care companies leading 2021’s Fortune 500 list
By
Sy Mukherjee
June 3, 2021
Newsletters
Abortion, Obamacare, and drug approvals: American health care faces a pivotal moment
By
Sy Mukherjee
May 27, 2021
Newsletters
Congress loves a Big Pharma villain. But will that lead to any real policy changes on drug prices?
By
Sy Mukherjee
May 20, 2021
Most Popular
Economy
America's $38 trillion national debt 'exacerbates generational imbalances' with Gen Z and millennials paying the price,...
By
Eleanor Pringle
Success
Meetings are not work, says Southwest Airlines CEO—and he’s taking action, by blocking his calendar every afternoon...
By
Preston Fore
Success
'I had to take 60 meetings': Jeff Bezos says 'the hardest thing I've ever done' was raising the first million dollars...
By
Dave Smith